Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Strata Skin Sciences, Inc. - Common Stock
(NQ:
SSKN
)
2.750
-0.200 (-6.78%)
Streaming Delayed Price
Updated: 9:30 AM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Strata Skin Sciences, Inc. - Common Stock
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 25, 2022
Gainers Tilray Brands (NASDAQ:TLRY) stock increased by 17.2% to $8.17 during Friday's pre-market session. The company's market cap stands at $3.9 billion. Sundial...
Via
Benzinga
Insiders Buying These 5 Penny Stocks
March 25, 2022
The Dow Jones surged around 350 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around...
Via
Benzinga
Strata Skin Sciences's Return On Capital Employed Insights
March 22, 2022
Strata Skin Sciences (NASDAQ:SSKN) brought in sales totaling $9.06 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 62.96%, resulting in a...
Via
Benzinga
Strata Skin Sciences: Q4 Earnings Insights
March 21, 2022
Strata Skin Sciences (NASDAQ:SSKN) reported its Q4 earnings results on Monday, March 21, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Earnings Scheduled For March 21, 2022
March 21, 2022
Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •...
Via
Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings
March 20, 2022
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...
Via
Benzinga
Earnings Outlook For Strata Skin Sciences
March 18, 2022
Strata Skin Sciences (NASDAQ:SSKN) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
January 19, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Orphazyme Preannounces Positive FY21 Results Orphazyme A/S (NASDAQ: ORPH)...
Via
Benzinga
60 Biggest Movers From Yesterday
February 10, 2022
Gainers US Ecology, Inc. (NASDAQ: ECOL) shares surged 67.7% to close at $47.25 on Wednesday after Republic Services reported it will buy the company at $48 per share in cash....
Via
Benzinga
The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In
January 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo...
Via
Benzinga
STRATA Skin Sciences Acquires Theravant's Acne Treatment Device, Expects Upside Q4 Sales
January 11, 2022
STRATA Skin Sciences Inc (NASDAQ: SSKN) expects Q4 FY21 sales of $8.8 million - $9.2 million, compared to $6.7 million in Q4 FY20 and the consensus of $8.19 million....
Via
Benzinga
36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021
October 04, 2021
RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5th - 8th, 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be...
From
MicroCap Rodeo
Via
AccessWire
Looking Into Strata Skin Sciences's Return On Capital Employed
October 04, 2021
According to data from Benzinga Pro, during Q2, Strata Skin Sciences's (NASDAQ:SSKN) reported sales totaled $7.38 million. Despite a 61.41% increase in earnings, the company...
Via
Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
September 09, 2021
Gainers IVERIC bio (NASDAQ:ISEE) shares ...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 30, 2021
Gainers Valneva (NASDAQ:VALN) stock rose 17.45% to $45.22 during Monday's pre-market session. The market value of their outstanding shares is at $2.2 billion....
Via
Benzinga
48 Stocks Moving In Tuesday's Mid-Day Session
August 17, 2021
Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares jumped 93% to $$8.10 after the company received a written pre-investigational new drug (pre-IND) response from the FDA...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 17, 2021
Gainers Forte Biosciences (NASDAQ:FBRX) stock increased by 16.38% to $27.7 during Tuesday's pre-market session. The market value of their outstanding shares is at $374...
Via
Benzinga
25 Stocks Moving in Tuesday's Pre-Market Session
August 17, 2021
Gainers Cardiol Therapeutics Inc. (NASDAQ: CRDL) shares rose 25.8% to $3.27 in pre-market trading after dropping around 7% on Monday. LM Funding America, Inc. (NASDAQ: LMFA) rose...
Via
Benzinga
Ra Medical To Focus On Peripheral Artery Disease With Pharos Dermatology Divestiture
August 17, 2021
Ra Medical Systems Inc (NYSE: RMED) has sold its Pharos dermatology business to STRATA Skin Sciences Inc (NASDAQ: SSKN) for $3.7 million in cash. The Pharos...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 16, 2021
Gainers Strata Skin Sciences (NASDAQ:SSKN
Via
Benzinga
Earnings Scheduled For August 16, 2021
August 16, 2021
Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter. • Data Storage (NASDAQ:DTST) is expected to...
Via
Benzinga
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
August 15, 2021
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
Earnings Scheduled For May 12, 2021
May 12, 2021
Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report...
Via
Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.